Importantly, treatment with DBF significantly affected genes TP53 and BCL2 encoding p53 and BCL2 family proteins related to cancer pathophysiology and resistance to conventional chemotherapy [35,36,37,38,39]. The gene discussed is BCL2; the disease is cancer.